Skip to content

BD Directigen EZ Flu A+B Assay

by Becton, Dickinson & CO 510(k)

Active United States

510(k) K101529

Overview

The BD Directigen EZ Flu A+B Assay is a rapid chromatographic immunoassay designed for the direct and qualitative detection of influenza A and B viral antigens. It falls under the category of devices detecting influenza A, B, and C virus antigens, as classified by regulatory authorities. This assay is intended for use with nasopharyngeal washes/aspirates, nasopharyngeal swabs, and throat swabs from symptomatic patients, providing a rapid diagnostic tool for influenza infection.

The device is supplied as a single-use immunoassay kit and is intended for use in clinical microbiology settings. It requires no special storage conditions beyond those specified in the accompanying instructions and is not intended for reuse. The assay is classified as a Class II medical device under FDA regulations and has received FDA 510(k) clearance. No specific MRI safety information is provided, and the device is not intended for use in MRI environments.

AI-generated from registry data, 20 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK101529 Date14 Jun 2010ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
PSZ
Device Class
Class II
Regulation
21 CFR Part 866.3328
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Other devices from Becton, Dickinson & Co.

See all devices from Becton, Dickinson & Co. →